You are here

edoxaban

Encouraging trial results for Daiichi anti-stroke therapy

The Pharma Letter

Fri, 05/18/18 - 09:41 pm

clinical trials

atrial fibrilation

Daiichi clot-buster wins a NICE green light, but still faces an uphill track

Fierce Biotech

Wed, 08/12/15 - 12:41 pm

FDA warning for blockbuster hopeful edoxaban hits Daiichi where it hurts

BioPharma Dive

Mon, 02/9/15 - 11:08 am

FDA Advisory Panel Gives Tepid Support To New Daiichi Sankyo Drug

Forbes

Fri, 10/31/14 - 02:01 pm

advisory panels

FDA staff recommends limited use of Daiichi's blood thinner

Yahoo/Reuters

Tue, 10/28/14 - 11:34 am

atrial fibrillation

Large Study Finds Favorable Risk-Benefit Profile For The New Anticoagulants

Forbes

Thu, 12/5/13 - 06:45 pm

Boehringer Ingelheim

Bristol-Myers Squibb

New Anticoagulant From Daiichi Sankyo Works Well In AF Patients

Forbes

Tue, 11/19/13 - 12:35 pm

atrial fibrillation

Daiichi Sankyo’s New Blood Thinner Matched Warfarin in Study

Bloomberg

Tue, 09/3/13 - 09:27 am